Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficacy in mouse autoimmune models
Abstract Regulatory T (Treg)-based cell therapy holds promise for autoimmune and inflammatory diseases, yet challenges remain regarding the functional stability and persistence of transferred Tregs. Here we engineer Tregs to express a partial agonist form of IL-2 (IL-2pa) to enhance persistence whil...
Saved in:
| Main Authors: | Janie Robert, Manon Feuillolay, María de Temple-Llavero, Reginald Florian Akossi, Vanessa Mhanna, Mustapha Cheraï, Gwladys Fourcade, Frédéric Charlotte, Nicolas Tchitchek, Tian Mi, Benjamin Youngblood, Thomas Vazquez, Michelle Rosenzwajg, David Klatzmann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-60082-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin-1 Links Autoimmune and Autoinflammatory Pathophysiology in Mixed-Pattern Psoriasis
by: Rodolfo Kölliker Frers, et al.
Published: (2021-01-01) -
Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease
by: Rong-hua Song, et al.
Published: (2017-01-01) -
Interleukin-27 and Autoimmune Disorders: A Compressive Review of Immunological Functions
by: Esmaeil Yazdanpanah, et al.
Published: (2024-11-01) -
Combining immune checkpoints with TNFSF agonists: a new horizon for cancer and autoimmune therapies
by: Lele Sun, et al.
Published: (2025-03-01) -
Thyroid Dysfunction after Gonadotropin-Releasing Hormone Agonist Administration in Women with Thyroid Autoimmunity
by: Loris Marin, et al.
Published: (2022-01-01)